OSR Health (OSRHW) Inventory Average (2025 - 2026)
OSR Health (OSRHW) posted Inventory Average of $229422.5 for Q1 2026, up 20.27% sequentially from $190763.5 in Q4 2025, and down 72.34% YoY from $829368.5 in Q1 2025.
OSR Health (OSRHW) Inventory Average (2025 - 2026) Analysis & Trends
OSR Health has reported Inventory Average for 2 years, with the latest figure at $229422.5 in Q1 2026.
- Quarterly Inventory Average fell 72.34% year-over-year to $229422.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $229422.5 (down 72.34% YoY) and the FY2025 annual result came in at $559269.5, changed N/A from the prior year.
- Inventory Average grew to $229422.5 in Q1 2026 per OSRHW's latest filing, from $190763.5 in the prior quarter.
- Over five years, Inventory Average peaked at $829368.5 in Q1 2025 and troughed at $190763.5 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 137.65 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 528,371.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229,422.50 |
| Dec 31, 2025 | 190,763.50 |
| Sep 30, 2025 | 191,961.00 |
| Jun 30, 2025 | 467,728.50 |
| Mar 31, 2025 | 829,368.50 |